Search by Drug Name or NDC

    NDC 45737-0218-16 Bio-B Kids 4; 15; 10 mg/5mL; mg/5mL; mg/5mL Details

    Bio-B Kids 4; 15; 10 mg/5mL; mg/5mL; mg/5mL

    Bio-B Kids is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by Advanced Generic Corporation. The primary component is CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 45737-0218
    Product ID 45737-218_8f7b3587-35d0-44be-a986-b9278d5cea53
    Associated GPIs
    GCN Sequence Number 051896
    GCN Sequence Number Description chlorpheniramine/phenyleph/DM LIQUID 4-10-15/5 ORAL
    HIC3 B3R
    HIC3 Description NON-OPIOID ANTITUS-1ST GEN.ANTIHISTAMINE-DECONGEST
    GCN 19347
    HICL Sequence Number 000375
    HICL Sequence Number Description CHLORPHENIRAMINE MALEATE/PHENYLEPHRINE HCL/DEXTROMETHORPHAN
    Brand/Generic Generic
    Proprietary Name Bio-B Kids
    Proprietary Name Suffix n/a
    Non-Proprietary Name Dextromethorphan,Chlorpheniramine Maleate, Phenylephrine
    Product Type HUMAN OTC DRUG
    Dosage Form LIQUID
    Route ORAL
    Active Ingredient Strength 4; 15; 10
    Active Ingredient Units mg/5mL; mg/5mL; mg/5mL
    Substance Name CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name Advanced Generic Corporation
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Rece
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2022-12-31

    Package

    NDC 45737-0218-16 (45737021816)

    NDC Package Code 45737-218-16
    Billing NDC 45737021816
    Package 473 mL in 1 BOTTLE (45737-218-16)
    Marketing Start Date 2009-10-01
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 0f33f96c-0817-47e7-95a8-456d34a98559 Details

    Revised: 12/2020